Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.1050
-0.0050 (-4.55%)
May 12, 2026, 4:10 PM AEST
Imugene Market Cap
Imugene has a market cap or net worth of 44.37 million as of May 12, 2026. Its market cap has decreased by -77.15% in one year.
Market Cap
44.37M
Enterprise Value
35.21M
Revenue
3.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 44.37M, an increase of 501.26%. That is a compound annual growth rate of 7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 42.35M | -63.41% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 73.45M |
| Radiopharm Theranostics | 67.34M |
| Amplia Therapeutics | 66.70M |
| Entropy Neurodynamics | 59.56M |
| Prescient Therapeutics | 56.78M |
| Neurizon Therapeutics | 56.72M |
| Avecho Biotechnology | 47.76M |
| NeuroScientific Biopharmaceuticals | 33.26M |